DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/kl6j7c/kidney_cancer) has announced the addition of the "Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Kidney Cancer (Renal Cell Cancer) and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Kidney Cancer (Renal Cell Cancer) Overview
- Therapeutics Development
- Pipeline Products for Kidney Cancer (Renal Cell Cancer) - Overview
- Pipeline Products for Kidney Cancer (Renal Cell Cancer) - Comparative Analysis
- Kidney Cancer (Renal Cell Cancer) - Therapeutics under Development by Companies
- Kidney Cancer (Renal Cell Cancer) - Therapeutics under Investigation by Universities/Institutes
- Kidney Cancer (Renal Cell Cancer) - Pipeline Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Kidney Cancer (Renal Cell Cancer) - Products under Development by Companies
- Kidney Cancer (Renal Cell Cancer) - Products under Investigation by Universities/Institutes
- Kidney Cancer (Renal Cell Cancer) - Companies Involved in Therapeutics Development
Companies Mentioned
- 4SC AG
- AbbVie Inc.
- Acceleron Pharma, Inc.
- Advanced Cancer Therapeutics
- Advaxis, Inc.
- Advenchen Laboratories, LLC
- Alethia Biotherapeutics Inc.
- Altor BioScience Corporation
- Ambrx, Inc.
- Amgen Inc.
- Ampio Pharmaceuticals, Inc.
- APEIRON Biologics AG
- arGEN-X BV
- Argos Therapeutics, Inc.
- ArQule, Inc.
- Arrowhead Research Corporation
- Astellas Pharma Inc.
- AstraZeneca Plc
- ATLAB Pharma SAS
- Aurigene Discovery Technologies Limited
- Bayer AG
- Beta Pharma, Inc.
- Beth Israel Deaconess Medical Center, Inc.
- BIND Therapeutics, Inc.
- Bio-Cancer Treatment International Limited
- Bionomics Limited
- Bionovis SA
- Boehringer Ingelheim GmbH
- Boston Biomedical, Inc.
- Bristol-Myers Squibb Company
- Caladrius Biosciences, Inc.
- Calithera Biosciences, Inc.
- CASI Pharmaceuticals Inc.
- Celgene Corporation
- Cellceutix Corporation
For more information visit http://www.researchandmarkets.com/research/kl6j7c/kidney_cancer